Emerge Partners Company Overview, Contact Details & Competitors

Q: What is Emerge Partners's official website and social media links?

Emerge Partners's official website is emerge360.com. Emerge Partners has social profiles on LinkedIn.

Q: How many employees does Emerge Partners have currently?

Emerge Partners has approximately 283 employees.

Q: What technology does Emerge Partners use?

Emerge Partners's tech stack includes Sirvoy, WordPress, COBOL, Python, Font Awesome.

Insights

Gathering insights about Emerge Partners…

Similar companies to Emerge Partners

Emerge Partners Tech Stack

Emerge Partners uses 8 technology products and services including RSS, Salesforce, Zoho Mail, and more. Explore Emerge Partners's tech stack below.

RSS
Content Management System
Salesforce
Customer Relationship Management
Zoho Mail
Email
IBM
IT
JSON-LD
Javascript Frameworks
React
Javascript Frameworks
jQuery
Javascript Libraries
MediaElement.js
Video Players

Media & News

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
GAITHERSBURG, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for its Winnipeg, Canada facility to be added as the drug product manufacturing and testing site for raxibacumab, a monoclonal antibody for the treatment and prophylaxis of inhalational anthrax.
Dec 12, 2025 | www.globenewswire.com
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (naloxone HCl) Nasal Spray as the first FDA-approved nasal naloxone spray for emergency treatment of opioid overdose.
Nov 18, 2025 | www.globenewswire.com
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) announced today that Dr. Louis W.
Nov 12, 2025 | www.globenewswire.com
Blueone Card Inc. Subsidiary Millennium EBS Partners with DFCC Bank in Sri Lanka to Implement ISO Transformer Solution
Los Angeles, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Blueone Card Inc. (OTCQX:BCRD) is pleased to announce that its wholly owned subsidiary, Millennium EBS Inc., has entered into an agreement with DFCC Bank in Sri Lanka to implement Millennium's advanced ISO Transformer solution for SWIFT messaging.
Nov 11, 2025 | www.globenewswire.com
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Emergent Biosolutions (EBS)
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Emergent Biosolutions (EBS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Nov 07, 2025 | www.zacks.com
Emergent BioSolutions: Solid Q3, Expecting Better Days To Come
Emergent BioSolutions maintains a Buy rating, supported by recent Q3 earnings beat and CEO Joe Papa's turnaround progress. EBS reported Q3 revenues of $231.1M and net income of $51.2M, surpassing guidance, with improved capital allocation and reduced net debt. Narcan sales declined year-over-year due to pricing and volume pressures, but sequential growth and strong demand signal market stabilization.
Nov 06, 2025 | seekingalpha.com
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?
Emergent Biosolutions (EBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Oct 31, 2025 | www.zacks.com

Emerge Partners's Email Address Formats

Emerge Partners uses at least 1 format(s):

Emerge Partners Email Formats	Example	Percentage
First.Last@emerge360.com	John.Doe@emerge360.com	81%
FLast@emerge360.com	JDoe@emerge360.com	9%
First@emerge360.com	John@emerge360.com	8%
FirstL@emerge360.com	JohnD@emerge360.com	2%

Frequently Asked Questions

Where is Emerge Partners's headquarters located?

Emerge Partners's main headquarters is located at 412 Linden Avenue Rochester, New York 14625 United States. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Emerge Partners's phone number?

You can contact Emerge Partners's main corporate office by phone at

+1-800-734-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Emerge Partners's stock symbol?

Emerge Partners is a publicly traded company; the company's stock symbol is EBS.

What is Emerge Partners's official website and social media links?

Emerge Partners's official website is emerge360.com and has social profiles on LinkedIn.

What is Emerge Partners's NAICS code?

Emerge Partners's NAICS code is 5416 - Management, Scientific, and Technical Consulting Services.

How many employees does Emerge Partners have currently?

As of February 2026, Emerge Partners has approximately 283 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Ceo Emerge: F. C.Chief Of Staff: B. C.Vice President Talent Acquisition And Operations: P. G.. Explore Emerge Partners's employee directory with LeadIQ.

What industry does Emerge Partners belong to?

Emerge Partners operates in the Business Consulting and Services industry.

What technology does Emerge Partners use?

Emerge Partners's tech stack includes RSSSalesforceZoho MailIBMJSON-LDReactjQueryMediaElement.js.

What is Emerge Partners's email format?

Emerge Partners's email format typically follows the pattern of First.Last@emerge360.com. Find more Emerge Partners email formats with LeadIQ.

When was Emerge Partners founded?

Emerge Partners was founded in 2012.

Insights

Similar companies to Emerge Partners

Technology Service Professionals

eMazzanti Technologies

Executech

ZAG Technical Services

Structured Communication Systems

Emerge Partners Tech Stack

Media & News

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Blueone Card Inc. Subsidiary Millennium EBS Partners with DFCC Bank in Sri Lanka to Implement ISO Transformer Solution

Looking for a Fast-paced Momentum Stock at a Bargain? Consider Emergent Biosolutions (EBS)

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?

Emerge Partners's Email Address Formats

Frequently Asked Questions

Where is Emerge Partners's headquarters located?

What is Emerge Partners's phone number?

What is Emerge Partners's stock symbol?

What is Emerge Partners's official website and social media links?

What is Emerge Partners's NAICS code?

How many employees does Emerge Partners have currently?

What industry does Emerge Partners belong to?

What technology does Emerge Partners use?

What is Emerge Partners's email format?

When was Emerge Partners founded?

Emerge Partners

Company Overview

Media & News

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?